Altered Glutamatergic Metabolism Associated with Punctate White Matter Lesions in Preterm Infants

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Wisnowski, Jessica L ^a,b   Blüml, Stefan ^a   Paquette, Lisa ^a   Zelinski, Elizabeth ^b   Nelson, Marvin D ^a   Painter, Michael J ^c   Damasio, Hanna ^b   Gilles, Floyd ^a   Panigrahy, Ashok ^a,c  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; LACTIC ACID;

ACIDOSIS; AMINO ACID METABOLISM; ARTICLE; BRAIN FUNCTION; DIFFUSE EXCESSIVE HIGH SIGNAL INTENSITY; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; EXCITOTOXICITY; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; INFANT; MAJOR CLINICAL STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PREMATURITY; WHITE MATTER LESION;

EID: 84874470457     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056880     Document Type: Article

References (58)

1. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, et al. (2010) The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. B World Health Organ 88: 31-38.
2. Saigal S, Doyle SW, (2008) Preterm birth 3: an overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 371: 261-269.
3. Banker BQ, Larroche JC, (1962) Periventricular leukomalacia of infancy. A form of neonatal anoxic encephalopathy. Arch Neurol 7: 386-410.
4. Gilles FH, Murphy SF, (1969) Perinatal telencephalic leukoencephalopathy. J Neurol Neurosur PS 32: 404-413.
5. Volpe JJ, Kinney HC, Jensen FE, Rosenberg PA, (2011) The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int J Dev Neurosci 29: 423-440.
6. Cornette LG, Tanner SF, Ramenghi LA, Miall LS, Childs AM, et al. (2002) Magnetic resonance imaging of the infant brain: anatomical characteristics and clinical significance of punctate lesions. Arch Dis Child-Fetal 86: F171-7.
7. Woodward LJ, Anderson PJ, Austin NC, Howard K, Inder TE, et al. (2006) Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med 355: 685-694.
8. Miller SP, Ferriero DM, Leonard C, Piecuch R, Glidden DV, et al. (2005) Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr 147: 609-16.
9. Miller SP, Ferriero DM, (2009) From selective vulnerability to connectivity: insight from newborn brain imaging. Trends Neurosci 32: 496-505.
10. Rutherford MA, Supramaniam V, Ederies A, Chew A, Bassi L, et al. (2010) Magnetic resonance imaging of white matter disease of prematurity. Neuroradiology 52: 505-521.
11. Maalouf EF, Duggan PJ, Rutherford MA, Counsell SJ, Fletcher AM, et al. (1999) Magnetic resonance imaging of the brain in a cohort of extremely preterm infants. J Pediatr 135: 351-357.
12. Riddle A, Dean J, Buser JR, Gong X, Maire J, et al. (2011) Histopathological correlates of magnetic resonance imaging-defined chronic perinatal white matter injury. Ann Neurol 70: 493-507.
13. Choi DW, Koh JY, Peter S, (1988) Pharamcology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci 8: 185-196.
14. Meldrum B, Garthwaite J, (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11: 379-387.
15. Lipton SA, Rosenberg PA, (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330: 613-622.
16. Hagberg H, Peebles D, Mallard C, (2002) Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev D R 8: 30-38.
17. Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, et al. (2004) Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 24: 4412-4420.
18. Manning SM, Talos DM, Zhou C, Selip DB, Park H-K, et al. (2008) NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 28: 6670-6678.
19. Volpe JJ (2008) Neurology of the newborn. 5th ed. Philadelphia: Elsevier. 1120 pages.
20. Daikhin Y, Yudkoff M, (2000) Compartmentation of brain glutamate metabolism in neurons and glia. J Nutr 130: 1026S-31S.
21. McKenna MC, (2007) The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain. J Neurosci Res 85: 3347-3358.
22. Rossi DJ, Brady JD, Mohr C, (2007) Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci 10: 1377-1386.
23. Salter MG, Fern R, (2005) NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438: 1167-1171.
24. Barkovich AJ, Miller SP, Bartha A, Newton N, Hamrick SE, et al. (2006) MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. Am J Neuroradiol 27: 533-47.
25. Robertson NJ, Kuint J, Counsell TJ, Rutherford TA, Coutts A, et al. (2000) Characterization of cerebral white matter damage in preterm infants using 1H and 31P magnetic resonance spectroscopy. J Cerebr Blood F Met 20: 1446-1456.
26. Kreis R, Hofmann L, Kulmann B, Boesch C, Bossi E, et al. (2002) Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 48: 949-958.
27. Xu D, Bonifacio S, Charlton NN, P Vaughan C, Lu Y, et al. (2011) MR spectroscopy of normative premature newborns. J Magn Reson Im 33: 306-311.
28. Kreis R, (2004) Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 17: 361-381.
29. Panigrahy A, Blüml S, (2007) Advances in magnetic resonance neuroimaging techniques in the evaluation of neonatal encephalopathy. Top Magn Reson Imag 18: 3-29.
30. Panigrahy A, Nelson MD, Blüml S, (2010) Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications. Pediatr Radiol 40: 3-30.
31. Blüml S, Wisnowski JL, Nelson MD, Paquette L, Gilles FH, et al. (2012) Metabolic maturation of the human brain from birth through adolescence: insights from in vivo magnetic resonance spectroscopy. Cereb Cortex doi:10.1093/cercor/bhs283.
32. Ernst T, Kreis R, Ross BD, (1993) Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J Magn Reson Im 102: 1-8.
33. Dobbing J, Sands J, (1973) Quantitative growth and development of human brain. Arch Dis Child 48: 757-767.
34. Smart JL, Dobbing J, Adlard BP, Lynch A, Sands J, (1973) Vulnerability of developing brain: relative effects of growth restriction during the fetal and suckling periods on behavior and brain composition of adult rats. J Nutr 103: 1327-1338.
35. Lentner C (1981) Geigy Scientific Tables. Basel, Switzerland: Ciba-Geigy. p 220-222, 223.
36. Sulyok E, Nyul ZZ, Bogner P, Berényi E, Repa I, et al. (2001) Brain water and proton magnetic resonance relaxation in preterm and term rabbit pupus: their relationship to tissue hyaluronan. Biol Neonate 2001 79: 67-72.
37. Matsumae M, Kurita D, Atsumi H, Haida M, Sato O, et al. (2001) Sequential changes in MR water proton relaxation time detect the process of rat brain myelination during maturation. Mech Ageing Dev 122: 1281-1291.
38. Back SA, Craig A, Kayton RJ, Luo NL, Meshul CK, et al. (2007) Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. J Cerebr Blood F Met 27: 334-347.
39. Chen J, Herrup K, (2012) Glutamine acts as a neuroprotectant against DNA damage, beta-amyloid and H2O2-included stress. PLOS One 7: e33177-e33188.
40. Newcomb R, Sun X, Taylor L, Curthoys N, Giffard RG, (1997) Increased production of extraceullar glutamate by the mitochondrial glutaminase following neuronal death. J Biol Chem 272: 11276-82.
41. Newcomb R, Pierce AR, Kano T, Meng W, Bosque-Hamilton P, et al. (1998) Characterization of mitochondrial glutaminase and amino acids at prolonged times after experimental focal cerebral ischemia. Brain Res 813: 103-11.
42. Torp R, Andine P, Hagberg H, Karagülle T, Blackstad TW, et al. (1991) Cellular and subcellular redistribution of glutamate, glutamine, and taurine-like immunoreactivities during forebrain ischemia: a semiquantitative electron microscopic study in rat hippocampus. Neuroscience 41: 433-447.
43. Richards DA, Tolias CM, Sqourous S, Bowery NG, (2003) Extracellular glutamine to glutamate ratio may predict outcome in the injured brain: a clinical microdialysis study in children. Pharmacol Res 48: 101-109.
44. Lei H, Berhet C, Hirt L, Gruetter R, (2009) Evolution of the neurochemical profile after transient focal cerebral ischemia in the mouse brain. J Cerebr Blood F Met 29: 811-819.
45. Haynes RL, Billiards SS, Borenstein NS, Volpe JJ, Kinney HC, (2008) Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fraction. Pediatr Res 63: 656-61.
46. Billiards SS, Haynes RL, Folkerth RD, Borenstein NS, Trachtenberg FL, et al. (2008) Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol 18: 153-63.
47. DeSilva TM, Billards SS, Borenstein NS, Trachtenberg FL, Volpe JJ, et al. (2008) Glutamate transporter EAAT2 expression is up-regulated in reactive astrocytes in human periventricular leukomalacia. J Comp Neurol 508: 238-248.
48. Blüml S, Moreno-Torres A, Ross BD, (2001) [1-13C] glucose MRS in chronic hepatic encephalopathy in man. Magn Reson Med 45: 981-93.
49. Patel TB, Clark JB, (1979) Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J 184: 539-546.
50. Urenjak J, Williams SR, Gadian DG, Noble M, (1992) Specific expression of N-acetyl-aspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors and immature oligodendrocytes in vitro. J Neurochem 59: 55-61.
51. Urenjak J, Williams SR, Gadian DG, Noble M, (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13: 981-989.
52. Bates TE, Strangward M, Keelan J, Davey GP, Munro PM, et al. (1996) Inhibition of N-acetylaspartate production: Implications for 1H MRS studies in vivo. Neuroreport 7: 1397-1400.
53. Clark JB, (1998) N-acetyl aspartate: A marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 20: 271-276.
54. Braissant O, Henry H, Villard AM, Speer O, Wallimann T, et al. (2005) Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. BMC Dev Biol 5: 9.
55. Sanchez-Gomez MV, Alberdi E, Ibarretxe G, Torre I, Matute C, (2003) Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. J Neurosci 22: 9519-9528.
56. Back SA, Riddle A, McClure MM, (2007) Maturation-dependent vulnerability of perinatal white matter in preterm birth. Stroke 38: 724-730.
57. Kidokoro H, Anderson PJ, Doyle LW, Neil JJ, Inder TE, (2011) High signal intensity of T2-weighted MR imaging at term-equivalent age in preterm infants does not predict 2-year neurodevelopmental outcomes. Am J Neuroradiol 32: 2005-2011.
58. Skiöld B, Vollmer B, Bohm B, Hallberg B, Horsch S, et al. (2012) Neonatal magnetic resonance imaging and outcomes at age 30 months in extremely preterm infants. J Pediatr 160: 559-566.